In this Diabetes in Real Life column, Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Mary-Elizabeth Patti, MD, and ...

A marketing authorization for Zegalogue (dasiglucagon, Zealand Pharma) for the treatment of severe hypoglycemia in patients aged 6 years and older with diabetes has been recommended by the European ...

As patients transition to geriatric care, considerations about treatment-related side effects, polypharmacy, comorbidities, and life expectancy become paramount. This is especially true for older ...

Chief Executive Officer Justin Klee said the company is preparing for a key Phase 3 readout for avexitide, its lead program ...

Fast-acting carbohydrates can treat mild hypoglycemia in 5 to 15 minutes. Prescription glucagon is used for severe hypoglycemia when fast-acting carbs don't help. If you don't have diabetes, see a ...

Phase 3 registrational trial for ersodetug in patients with tumor hyperinsulinism (HI) expected to commence in 2025; real-world patient benefit demonstrated in Expanded Access Program REDWOOD CITY, ...

(RTTNews) - Rezolute, Inc. (RZLT),a late-stage biopharmaceutical company, Tuesday said that the U.S. Food and Drug Administration or FDA has granted orphan drug designation to ersodetug for the ...

Medically reviewed by Simone Harounian, MS Foods high in sugar, like juice, candies, or honey, can quickly raise your blood ...